2026 pediatric dermatology research alliance (pedra) annual conference

Active Project Grant Awarded Last action

Award ID
R13AR088333
Recipient
Awarding agency
Obligated
$74,999

Award facts

Assistance listing
93.846 Arthritis, Musculoskeletal and Skin Diseases Research
Completion date 13% complete
Place of performance
Portland, OR 97202, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Pediatric skin diseases are highly prevalent and impart a devastating burden on children and their families. Yet, the specialty of pediatric dermatology is understaffed, the availability of FDA- approved treatments is inadequate, and the pace of research and guidelines development in the field is too slow. The pediatric dermatology research alliance (pedra) was founded in 2012 to address these crucial yet unmet needs. Pedra's primary mission is to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease. The long-term goal of pedra is to leverage such research to improve the health outcomes of children with skin disorders. Annual conferences have been integral to the success of pedra, providing a forum for educating investigators, identifying and prioritizing research needs and opportunities, and developing and initiating innovative projects. A combination of didactic lectures and panels, expert-led small group discussions, poster sessions, and unique training opportunities are the foundation of every pedra annual conference. This proposal is for the 14TH pedra annual conference, set to take place in october of 2026 with the following aims: 1) provide education, presentation, and networking opportunities that engage a broad audience while equipping attendees to make use of limited time and resources to advance science that improves the lives of children with skin diseases and conditions; 2) advance existing research projects and develop new research priorities and initiatives in disease areas and high-priority topics spanning the field of pediatric dermatology; and 3) provide a forum for the dissemination of final and ongoing research results to a large audience that includes patient stakeholders, industry representatives, and researchers from multiple fields including potential NIH collaborators. The expected outcomes of this conference are a more developed set of research skills for current and future physician-scientists, enhanced productivity, strengthened multi-stakeholder networks, and the conduct of high-quality research. These activities will accelerate the pace of pediatric dermatology research, allowing clinicians to better understand, prevent and treat skin disease in children, and giving patients and families options to manage diseases and make informed treatment decisions in the future.

Quick answers

Who received award R13AR088333?

R13AR088333 was awarded to Pediatric Dermatology Research Alliance Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 1, 2026.

How much is award R13AR088333 worth?

$74,999 has been obligated on R13AR088333.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login